ENGINEERING GENE REGULATORY NETWORKS FOR IMPROVED THERAPEUTIC STEM CELL DIFFERENTIATION OUTCOMES

Abstract

Background: Stem cell-based therapies have become important in regenerative medicine and tissue engineering . However, the significant hurdles for successful therapeutic application still remain, as there is a lack of control over stem cell differentiation and instability of lineage commitment.

Objective: This study aimed to design gene regulatory networks (GRNs) to improve the efficiency, lineage specificity, and therapeutic stability of stem cell differentiation by synthetic biology and CRISPR-based methods.
Methodology: Human induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs) were genetically modified by CRISPR-Cas9 based transcriptional activation and synthetic gene circuit engineering. To evaluate regulatory pathways and gene expression associated with differentiation, we used transcriptomic profiling, quantitative PCR, RNA sequencing and bioinformatics analyses.

Findings: The engineered GRNs improved the efficiency of stem cell differentiation significantly, raising neuronal lineage differentiation from 52% in control cells to 81% in engineered iPSCs and cardiac differentiation efficiency to 76% in modified MSCs. Lineage-specific transcription factors, such as SOX2 (3.5-fold) and NKX2-5 (4.1-fold), were upregulated. Engineered regulatory circuits also reduced off-target differentiation while increasing cellular maturation and stability.

Conclusion: The study demonstrates that genetic engineering of gene regulatory networks can effectively improve the therapeutic outcomes of stem cell differentiation and supports the development of advanced strategies for regenerative medicine and personalized cell therapy.